Reflow Medical Announces 510(k) Clearance for an Expanded Indication for the Wingman Catheter to Cross Chronic Total Occlusions (CTOs) in Peripheral Artery Disease SAN CLEMENTE, March 5, 2020 /BUSINESS WIRE/…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical announces that the Temporary Spur Stent System, a novel retrievable stent technology intended for the treatment of below-the-knee (BTK) peripheral artery disease, has been designated…
San Clemente, Calif., July 30th, 2019–(BUSINESS WIRE) — Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER…
San Clemente, Calif., April 10th, 2019–(BUSINESS WIRE)– Reflow Medical, Inc. has announced the completion of enrollment in its Wing-IT investigational device exemption trial, a prospective, multicenter, nonrandomized study evaluating the…
Dr. Jihad Mustapha of Grand Rapids, Michigan, explains how the Spur device, a spiked self-expanding stent is intended for use in conjunction with a drug-coated balloon, can help drug delivery…
Dr. Mathews, Director of the Cardiac Catheterization Laboratory at Manatee Memorial Hospital in Bradenton, Florida, joined Reflow Medical, Inc. at the conclusion of the Transcatheter Cardiovascular Therapeutics (TCT) symposium held…
View the Reflow video featured at the Hilton Chicago this week during AMP 2018.
Non-Randomized Study Evaluating the Use of the Reflow Medical Wingman Catheter to Cross Chronic Total Occlusions in Infrainguinal Peripheral ArTeries) SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical Inc., a developer of innovative medical devices…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)— Reflow Medical, Inc., a developer and innovator of crossing and support catheters for use in the treatment of occlusive cardiovascular disease, announced that the company has…
Recent Comments